Avizia has announced a partnership with Regroup that will allow the telehealth company to offer comprehensive mental health services through its platform. The new telepsychiatry service will be staffed by Regroup’s provider network, and available to the health systems Avizia serves.
“Like Avizia, Regroup was founded on the idea that no patient should have to worry about access to high-quality healthcare, regardless of their geographic location, socio-economic status or level of need,” Mike Baird, founder and CEO of Avizia, said in a statement. “Regroup is disrupting the image of mental healthcare as an exclusive service limited to therapists’ couches or hospital rooms. By helping organizations launch or enhance their behavioral health programs, Regroup is improving the lives of patients immeasurably.”
Healthgrades’ online search tool for identifying physicians who specialize in treating those with cancer is now featured on the American Cancer Society’s website, . The physician and hospital rating service’s search tool will allow users to search oncologists by city, state, or zip code.
“Healthgrades is thrilled to work with the American Cancer Society to provide cancer patients and caregivers access to accurate, objective information about physicians,” Mike Rosenberg, SVP of national advertising at Healthgrades, said in a statement. “Pairing our physician finder capability with Cancer.org provides patients a one-stop shop to research cancer, learn about treatments, get involved in the American Cancer Society and find oncologists.”
The University of Arkansas for Medical Sciences has chosen MyMeds’ Digital + Human platform for an upcoming research study on the impact of digital solutions on medication adherence, according to a statement. The platform is designed to allow prescription-related information to populate in real-time, let patients use the service on multiple devices, and combine technology with a human clinical team to better target patients’ adherence behaviors.
“We are excited to partner with MyMeds for our research,” Seth Heldenbrand, associate dean of experiential education and associate professor of pharmacy practice at the university, who will lead the research team, said in a statement. “Their Digital + Human approach to changing medication-taking behaviors, and their ability to connect to any PBM, stands apart from all the technologies that we have seen. We have been studying and testing the best available adherence apps since 2011, and MyMeds has always been a top performer from the perspectives of users and providers.”
Thanks to a deal with workflow automation company nVoq, practice management software maker CareCloud has added a speech recognition tool to reduce click-based tasks in EHRs, the companies announced yesterday. The tech, called SayIt, is available through CareCloud’s Connect Partner program, and can be used with a computer or smartphone’s microphone.
“Making medical speech recognition technology available on our platform is another way that we are improving the productivity of physicians by giving them the tools they are asking for,” Juan Molina, CareCloud’s vice president of strategy and business development, said in a statement. “The open architecture of our cloud platform allows us to deliver technology of all kinds to our clients in a way that makes it easy for them to use and integrate into their daily clinical and practice management workflows.”
Alongside a newly announced investment, VSP Global and healthcare commerce platform PokitDok have partnered to explore and test the laters HIPAA-compliant blockchain network, called DokChain.
“Blockchain is an essential next step to achieve the heightened levels of security, flexibility, efficiency and transparency that the current healthcare market demands,” Ted Tanner, Jr., co-founder and CTO of PokitDok, said in a statement. “We are pleased to test and deploy DokChain-enabled healthcare solutions with VSP Global, especially given their history of innovation.”
CRF Health’s electronic Clinical Outcome Assessment tools have received the nod for an upcoming insomnia trial being held by an unnamed European pharmaceutical company, according to a release. CRF’s TrialMax Touch and TrialMax Slate will be made available to use on-site and on home-based devices to record patients and clinicians’ assessments through the investigation.
“CRF Health prides itself on providing expert advice on both patient and clinician reported outcomes to support central nervous system- related clinical studies. Our strength comes from not simply handing over devices but supporting study teams and delivering best practice for training and user acceptance,” Rachael Wyllie, CRF Health’s CEO, said in a statement.